gyki 52466 has been researched along with Subarachnoid Hemorrhage in 1 studies
GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source
Subarachnoid Hemorrhage: Bleeding into the intracranial or spinal SUBARACHNOID SPACE, most resulting from INTRACRANIAL ANEURYSM rupture. It can occur after traumatic injuries (SUBARACHNOID HEMORRHAGE, TRAUMATIC). Clinical features include HEADACHE; NAUSEA; VOMITING, nuchal rigidity, variable neurological deficits and reduced mental status.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In the present study the activity of bimoclomol was tested in experimental subarachnoid hemorrhage (SAH) and arachidonic acid (AA)-induced brain edema in rats to elucidate whether the compound may also have beneficial effect in cerebrovascular disturbances." | 7.70 | Bimoclomol protects against vascular consequences of experimental subarachnoid hemorrhage in rats. ( Erdö, F; Erdö, SL, 1998) |
| " In the present study the activity of bimoclomol was tested in experimental subarachnoid hemorrhage (SAH) and arachidonic acid (AA)-induced brain edema in rats to elucidate whether the compound may also have beneficial effect in cerebrovascular disturbances." | 3.70 | Bimoclomol protects against vascular consequences of experimental subarachnoid hemorrhage in rats. ( Erdö, F; Erdö, SL, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erdö, F | 1 |
| Erdö, SL | 1 |
1 other study available for gyki 52466 and Subarachnoid Hemorrhage
| Article | Year |
|---|---|
Bimoclomol protects against vascular consequences of experimental subarachnoid hemorrhage in rats.
Topics: Animals; Anti-Anxiety Agents; Arachidonic Acid; Benzodiazepines; Brain Edema; Cerebral Angiography; | 1998 |